- 1. I cell disease
- [rapidly progressing disease of young children, characterized histologically by abnormal fibroblasts containing a large number of dark inclusions which fill the central part of the cytoplasm except for the juxtanuclear zone (I cells), and clinically by severe growth impairment, minimal hepatomegaly, extreme mental and motor retardation, and clear corneas; inherited as an autosomal recessive trait, it is caused by failure of lysosomal enzymes to be incorporated into lysosomes. ( CSP )] (UMLS (CSP) C0020725) =Disease or Syndrome =inborn lipid storage disorder;
inborn lysosomal enzyme disorder | - 23. ICI 176334
- (UMLS (NCI) C0740019) =Organic Chemical; Pharmacologic Substance
|
- 2. I-CORONARY
- [Intracoronary ( HL7V3.0 )] (UMLS (NCI) C0595454) =Functional Concept ;
=RouteBySite;
=Infusion, intracoronary;
Injection, intracoronary | - 24. ICI 182,780
- [A drug that blocks estrogen activity in the body and is used in the therapy of estrogen-dependent tumors such as breast cancer. ( NCI )] (UMLS (NCI) C1123005) ICI 182780 =Steroid; Pharmacologic Substance ;
|
- 3. IC
- [between meals (from lat. inter cibus) ( HL7V3.0 )] (UMLS (HL7) C1550740) =Temporal Concept =TimingEvent;
| - 25. ICI 46,474
- (UMLS (NCI) C0700621) =Organic Chemical; Pharmacologic Substance ;
|
- 4. IC
- [A country in Northern Europe, island between the Greenland Sea and the North Atlantic Ocean, northwest of the UK. (NCI) ( NCI )] (UMLS (NCI) C0020750) =Geographic Area
| - 26. ICI 59118
- (UMLS (NCI) C0877950) ICRF 159;
ICRF159;
ICRF-159 =Organic Chemical; Pharmacologic Substance |
- 5. Ic351
- (UMLS (NCI) C0967375) =Organic Chemical; Pharmacologic Substance ;
| - 27. ICI D1033
- (UMLS (NCI) C0733865) ICI-D1033;
=Organic Chemical; Pharmacologic Substance ;
|
- 6. ICAM
- [ ] (UMLS (CSP) C0598077) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 28. ICI D1694
- (UMLS (NCI) C0123106) =Organic Chemical; Pharmacologic Substance
|
- 7. ICAM1
- [This gene is involved in mediating integrin-binding interactions that result in cellular adhesion. ( NCI )] (UMLS (NCI) C1334074) ICAM1 Gene;
Intercellular Adhesion Molecule 1 (CD54), Human Rhinovirus Receptor Gene;
=Gene or Genome ;
| - 29. ICI-118630
- (UMLS (NCI) C0701275) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 8. ICAM2
- [This gene is involved in antigen-specific immune responses and NK-cell clearance. ( NCI )] (UMLS (NCI) C1334075) ICAM2 Gene;
Intercellular Adhesion Molecule 2 Gene;
=Gene or Genome ;
| - 30. Iclaprim
- (UMLS (NCI) C1452002) =Organic Chemical; ;
|
- 9. ICAM3
- [This gene is involved in the mediation of cellular adhesion, immune responses, and signal transduction. ( NCI )] (UMLS (NCI) C1334076) ICAM3 Gene;
Intercellular Adhesion Molecule 3 Gene;
=Gene or Genome ;
| - 31. ICM
- [between breakfast and lunch ( HL7V3.0 )] (UMLS (HL7) C1550746) =Temporal Concept =TimingEvent;
|
- 10. ICC
- [An malignant tumor composed of cells resembling those of bile ducts. Cholangiocarcinoma is a relatively rare tumor in most populations. It can arise from any portion of the intrahepatic bile duct epithelium or the hepatic ducts. Grossly, the lesions are nodular, grayish-white firm and solid. Microscopically, the vast majority of cholangiocarcinomas are adenocarcinomas showing tubular and/or papillary structures. Early detection of cholangiocarcinomas is difficult, and the overall prognosis after resection is poor (adapted from WHO, 2000). —2002 ( NCI )] (UMLS (NCI) C0345905) =Neoplastic Process
| - 32. ICN 1229
- (UMLS (NCI) C0702025) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
|
- 11. ICCS
- (UMLS (HL7) C1611822) =Intellectual Product =Code;
◊ [Commission on Professional and Hospital Activities, 1968 Green Road, Ann Arbor, MI 48105. ( HL7V3.0 )] (UMLS (HL7) C1550220) Intellectual Product CodeSystem; | - 33. Icofungipen
- (UMLS (NCI) C1174269) =Amino Acid, Peptide, or Protein; ;
|
- 12. ICD
- [between lunch and dinner ( HL7V3.0 )] (UMLS (HL7) C1550747) =Temporal Concept =TimingEvent;
| - 34. Icon
- [hybrid molecule specifically designed to deliver a toxin to a specific cell or tissue. ( CSP )] (UMLS (NCI) C0243020) =Pharmacologic Substance; Immunologic Factor =Ab;
|
- 13. ICD
- [A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12). (NCI) ( NCI )] (UMLS (NCI) C0870733) International Classification of Diseases =Intellectual Product ;
| - 35. Icotidine
- (UMLS (NCI) C0063315) =Organic Chemical; Pharmacologic Substance
|
- 14. ICD-10
- [World Health Publications, Albany, NY. ( HL7V3.0 )] (UMLS (HL7) C1137110) =Intellectual Product =Code;
CodeSystem | - 36. ICP/MS
- [A mass spectrometry technique that uses inductively-coupled plasma generated from argon gas to atomize and ionize a sample. The resulting ions are separated and analyzed using a mass spectrometer. ( NCI )] (UMLS (HL7) C1553183) ICPMS;
ICP-MS;
Inductively Coupled Plasma Mass Spectrometry;
Inductively-Coupled Plasma Mass Spectrometry =Laboratory Procedure =ObservationMethod;
|
- 15. ICD-10 Australian modification
- (UMLS (HL7) C1550218) =Intellectual Product =Code;
| - 37. ICP47
- [ ] (UMLS (CSP) C0599802) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 16. ICD-10 Canada
- (UMLS (HL7) C1550219) =Intellectual Product =Code;
| - 38. ICR
- (UMLS (NCI) C0025925) =Mammal ;
|
- 17. ICD-10 Procedure Codes
- [Procedure Coding System (ICD-10-PCS). See http://www/hcfa.gov/stats/icd10.icd10.htm for more information. ( HL7V3.0 )] (UMLS (HL7) C1550212) =Intellectual Product =Code;
CodeSystem | - 39. ICRF-187
- (UMLS (NCI) C0733406) =Organic Chemical; Pharmacologic Substance
|
- 18. ICD-9CM
- [Commission on Professional and Hospital Activities, 1968 Green Road, Ann Arbor, MI 48105 (includes all procedures and diagnostic tests). ( HL7V3.0 )] (UMLS (HL7) C1550214) =Intellectual Product =Code;
CodeSystem | - 40. ICS 205-930
- (UMLS (NCI) C0701391) =Organic Chemical; Pharmacologic Substance
|
- 19. ICD9
- [World Health Publications, Albany, NY. ( HL7V3.0 )] (UMLS (HL7) C1550213) =Intellectual Product =Code;
CodeSystem | - 41. ICSH
- [major gonadotropin secreted by the adenohypophysis; luteinizing hormone regulates steroid production by the interstitial cells of the gonads; the preovulatory luteinizing hormone surge in females induces ovulation and subsequent luteinization of the follicle. ( CSP )] (UMLS (CSP) C0023607) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone ;
=[HS400] GONADOTROPINS;
neuropeptide;
[HS000] HORMONES / SYNTHETICS / MODIFIERS;
=LUTEINIZING HORMONE 150 UNT;
LUTEINIZING HORMONE 75 UNT;
|
- 20. ICHPPC-2
- [International Classification of Health Problems in Primary Care, Classification Committee of World Organization of National Colleges, Academies and Academic Associations of General Practitioners (WONCA), 3rd edition. An adaptation of ICD9 intended for use in General Medicine, Oxford University Press. ( HL7V3.0 )] (UMLS (HL7) C1550217) =Intellectual Product =Code;
CodeSystem | - 42. Icterus
- [An observation that describes the icterus index of the specimen. It is recommended to use mMol/L of bilirubin ( HL7V3.0 )] (UMLS (HL7) C1553190) =Idea or Concept =ActSpecObsInterferenceCode;
|
- 21. ichthyotoxin
- [ ] (UMLS (CSP) C0304166) =Amino Acid, Peptide, or Protein; Biologically Active Substance; Hazardous or Poisonous Substance
| - 43. ICV
- [between dinner and the hour of sleep ( HL7V3.0 )] (UMLS (HL7) C1550748) =Temporal Concept =TimingEvent;
|
- 22. ICI 123215
- (UMLS (NCI) C0701274) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| |
home
